NCT02502266 · Interventional trial
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Adenocarcinoma, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Primary Peritoneal Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma
Delaware Valley sites
- Asplundh Cancer Pavilion · Willow Grove, PA · Montgomery County
- Bryn Mawr Hospital · Bryn Mawr, PA · Montgomery County
- Cooper Hospital University Medical Center · Camden, NJ · Camden County
- Jefferson Abington Hospital · Abington, PA · Montgomery County
- Lankenau Medical Center · Wynnewood, PA · Montgomery County
- MD Anderson Cancer Center at Cooper-Voorhees · Voorhees Township, NJ · Camden County
- Paoli Memorial Hospital · Paoli, PA · Chester County
- The Cancer Institute of New Jersey Hamilton · Hamilton, NJ · Mercer County
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory